Neochem Bio Solutions Ltd. · NSE:NEOCHEM
Neochem Bio Solutions — H1 FY27 Earnings Presentation
31 slides from Neochem Bio Solutions's earnings presentation, Oct 29, 2026
Slide 1: Cover letter to NSE under Regulation 30
Date: 29th October, 2026 To, Listing Department, National Stock Exchange of India Limited Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Bandra (E) Mumbai – 400 051 Symbol: NEOCHEM, ISIN: INE21UM01018 Sub.: Submission of Investor Presentation pursuant to Regulation 30 of SEBI (Listing Obligatio
Slide 2: H1 FY27 Earnings Update Investor Presentation
NSE – SME: NEOCHEM Investor Presentation H1 FY27 Earnings Update The backbone of India’s industrial chemistry
Slide 3: Table of Contents
TABLE OF CON T E N T S 03 05 16 Performance update Company Market Opportunity H1 FY27 Overview 19 24 29 Financial Performance Our Right To Win Investment rationale & Track Record
Slide 4: Executive Summary – H1 FY27
Executive Summary – H1 FY27 Performance update Revenue from INR 68.9 crores Return on equity 17.4% operations (ROE) (vs 24.4% in FY26) (+50% y-o-y) INR 12.4 crores Return on capital 27.1% EBITDA employed (ROCE) (vs 36.8% in FY26) (+25% y-o-y) 18.0% Debtor days 127 days EBITDA margin (vs 161 days in
Slide 5: Company Overview
TABLE OF CON T E N T S 03 05 16 Performance update Company Market Opportunity H1 FY27 Overview 19 24 29 Financial Performance Our Right To Win Investment rationale & Track Record
Slide 6: Neochem Bio Solutions at a glance
Neochem Bio Highlights: Solutions at a glance Company Overview 4 50+ Neochem Bio Solutions Limited manufactures specialty Core product segments: performance chemicals for industries including: Polymers, Surfactants, Pan-India authorized Silicones, Esters and distributors serving 225+ • Textile and g
Slide 7: Manufacturing facility (1/2)
Flexible infrastructure supporting customized specialty chemical formulations Manufacturing facility (1/2) LOCATION Moraiya, Ahmedabad MANUFACTURING AREA Production Warehouse Quality 6,763 sq. m. Flexible batch manufacturing 1,350 MT storage capacity In-house QC and application across polymers, surf
Slide 8: Manufacturing facility (2/2)
Controlled process ensuring consistent, reliable product performance Manufacturing facility (2/2) 01 Water Charging 02 Reactor Heating Reactor system: Precision & control at every step Raw Material Feed Pipe Motor Feed 04 Testing & Weighing 03 Charging Raw Materials Temperature Cooling Jacket Measur
Slide 9: Product segments and applications (1/2)
Broad portfolio of performance chemistries across end markets Product segments and its applications (1/2) 1. Polymers 2. Surfactants Backbone chemistries that bind, thicken and Active cleaning agents that let water lift away oil, stabilize, enhancing finish, flow and durability dirt and pigment: the
Slide 10: Product segments and applications (2/2)
Broad portfolio of performance chemistries across end markets Product segments and its applications (2/2) 3. Silicones 4. Ester & Bio-Based Sustainable Solutions Performance finishes that make fabrics soft and smooth while adding water, Plant-based, eco-friendly softeners and conditioners stain and
Slide 11: Deep application expertise across diverse end markets
Deep application expertise across diverse end markets Industry applications Textile and Industrial Personal Care Water Home Care Garment Cleaners Treatment Specialty Construction Paper Paints and Coatings Chemicals for Rubber Chemicals and Pulp Dyes & Pigments INVESTOR PRESENTATION H1 FY27 – NEOCHEM
Slide 12: Quality control & certifications
Robust quality systems and sustainability-led manufacturing standards Quality control & certifications CERTIFICATIONS QUALITY CONTROL AND ASSURANCE Global organic In-house QC/QA Lab textile standard Dedicated lab with analytical and application-based testing (GOTS 7.0) capabilities. Experienced over
Slide 13: Four decades of enabling growth
Four decades of enabling growth Our timeline 2026 2025 2024 2023 • Achieved revenue of more than ₹11,000 • Converted to public limited company • Launch of home and personal care ingredients Entered into international Lakhs in FY26 and changed the name to Neochem Bio product business in countries lik
Slide 14: Management overview
Experienced promoter-led management with industry expertise Management overview Mr. Swapnil Ms. Hemangini Mr. Dinesh Chopra Mr. Rajasekaran Guha Mr. Falgunbhai Mr. Shail Jayesh Shah Rameshbhai Swapnil Prajapati Makati Dathia Chairman & Non- Non-Executive Non-Executive Non-Executive Managing Director
Slide 15: Sales and marketing strategy
Established customer relationships supported by a wide distribution network Sales and marketing strategy Revenue Split (%) – FY26 5% Pan-India distribution strength anchors growth, with 95% exports emerging as the next lever Domestic J Export F H L B K Together, these four pillars turn market reach
Slide 16: Market Opportunity
TABLE OF CON T E N T S 03 05 16 Performance update Company Market Opportunity H1 FY27 Overview 19 24 29 Financial Performance Our Right To Win Investment rationale & Track Record
Slide 17: India's specialty chemicals and bioeconomy: a structural growth opportunity
India’s specialty chemicals and bioeconomy: a structural growth opportunity Industry overview (1/2) Why india’s advantage is structural: Global performance chemical industry by application (in USD billion) China+1 is reshaping global supply chains 2024 | 2029P 41.2 Rising costs and stricter environm
Slide 18: Textile chemicals: a high-growth specialty segment
Textile chemicals: a high-growth specialty segment Industry overview (2/2) India’s textile chemicals market is riding a structural shift toward premium, sustainable, higher -value manufacturing. Domestic textile chemical industry market size (in Rs Domestic market size for specialty chemicals indust
Slide 19: Financial Performance & Track Record
TABLE OF CON T E N T S 03 05 16 Performance update Company Market Opportunity H1 FY27 Overview 19 24 29 Financial Performance Our Right To Win Investment rationale & Track Record
Slide 20: Historical business performance (1/2)
Historical business performance (1/2) All currencies is in ₹ crores, unless otherwise mentioned Revenue from operations EBITDA Profit after tax (PAT) 35% (2YR CAGR) 33.0 82% (2YR CAGR) 1.2 166% (2YR CAGR) 28.0 1 14.0 23.0 0.8 12.0 18.0 10.0 0.6 8.0 110.7 13.0 22.6 84.2 0.4 6.0 12.0 61.1 14.8 8.0 7.4
Slide 21: Historical business performance (2/2)
Historical business performance (2/2) All currencies is in ₹ crores, unless otherwise mentioned Return on equity (ROE) Return on capital employed (ROCE) Net debt to equity ratio (D/E) 744 b p s (OVE R 2YR) 1,550 b p s (OVE R 2YR) 2.4x (OVE R 2YR) 32.0% 1.2 27.0% 1 40.9% 22.0% 0.8 36.8% 46.6% 17.0% 2
Slide 22: Income Statement
Income Statement All currencies is in ₹ crores, unless otherwise mentioned Particulars H1 FY266 H1 FY277 YoY change FY24 FY25 FY26 YoY change Revenue from Operations 45.8 68.9 50% 61.1 84.2 110.7 32% Other Income 1.4 0.4 -73% 0.9 2.0 2.7 36% Total Income 47.2 69.3 47% 62.0 86.2 113.4 32% Cost of m
Slide 23: Balance sheet
Balance sheet All currencies is in ₹ crores, unless otherwise mentioned Equity and Liabilities FY24 FY25 FY26 H1 FY27 Assets FY24 FY25 FY26 H1 FY27 Share capital 6.7 6.7 17.1 17.1 Non-current assets: Reserves & surplus 5.3 13.1 61.7 69.6 Tangible assets 18.8 18.7 19.9 30.9 Minority interest - - - -
Slide 24: Our Right To Win
TABLE OF CON T E N T S 03 05 16 Performance update Company Market Opportunity H1 FY27 Overview 19 24 29 Financial Performance Our Right To Win Investment rationale & Track Record
Slide 25: Our right to win
Well-positioned specialty chemical platform with strong execution capabilities Our right to win Flexible infrastructure for Robust quality & sustainability-led Deep application expertise across customized formulations manufacturing diverse markets • In-house production of key intermediates and • In-
Slide 26: Business strategies
Multiple strategic initiatives positioned to drive next phase of growth Business strategies 01 Strengthening presence across end-user industries 03 Sustained development of performance chemistries • Diversifying product applications across multiple high-potential • Advancing bio-based alternatives t
Slide 27: New product launches across key end markets
New product launches across key end markets New product offerings FabBrite 9000 FabBrite 9002 Ampinol RDP-CW Ampinol LDT Avakote JCW Wax Integrated Pretreatment Sustainable Accelerated Advanced Rheology High-Performance Efficiency Solution One-Bath Processing Textile Washing Control Agent Surface En
Slide 28: Innovation engine: R&D focus areas
Innovation-driven R&D supporting sustainable growth Innovation engine: Neochem’s R&D focus areas FO C U S A R E A 1 FO C U S AR E A 2 FO C U S AR E A 3 Process innovation & Sustainable and bio- Application-led innovation & efficiency based products partnerships • Chemistries that cut process time, •
Slide 29: Investment Rationale
TABLE OF CON T E N T S 03 05 16 Performance update Company Market Opportunity H1 FY27 Overview 19 24 29 Financial Performance Our Right To Win Investment rationale & Track Record
Slide 30: A scalable platform powered by innovation & diversification
A scalable platform powered by innovation & diversification Investment rationale Diversified specialty Innovation & sustainable Proven execution with chemicals platform growth strategy scalable platform 350+ ZLD 40+ years Customized formulations Zero Liquid Discharge facility Operating legacy 4 ZDHC
Slide 31: Thank You
Thank You Neochem Bio Solutions Limited Shradha Agarwal Email: [email protected] Investor Relations Consultant Meeting Request Link NeoAtlas Capital Advisory LLP Pranil Pandya Rutul Shah +91 84012 07703 +91 82002 47366 [email protected] [email protected] INVESTOR PRESENTATION H1FY27
Neochem Bio Solutions — H1 FY27 Earnings Presentation on 6ix